Martínez-Mier G, Méndez-López MT, Budar-Fernández LF, Ávila-Pardo SF, González-Velázquez F

Language: Spanish
References: 21
Page: 42-49
PDF size: 243.04 Kb.

ABSTRACT

Objectives: Early conversion from CNI to MMF/SRL regimen has shown benefits in graft function and patient/graft survival with low rejection rate in kidney transplantation. We evaluated the early conversion impact of MMF/SRL in patients withdrawn from CNI. Material and Methods: We prospectively followed 32 patients converted from CNI to SRL before 12 months following transplantation during 25 months. Patients underwent abrupt CNI cessation with SRL introduction and adjustment to maintain 5-10 ng/mL levels. MMF decreased to 1-1.5 gr/day. Results: 19 patients (59.4%) were male. Mean age was 29.6 ± 9.8 years. Most grafts were living donors (n=26, 81.3%). Mean donor age was 41.7 ± 9.5 years. Mean SRL conversion time was 6.1 ± 2.8 months. Postconversion acute rejection rate was 6.25%. All patients has been followed for 9 months. Patient/graft survival was 96 & 90%. BUN decreased throughout the study (p‹0.05), SCr improved (p‹0.005) up to 12 months of follow-up. Mean estimated GFR increased (p‹0.005) up to 18 months of follow-up. 24 hour urine protein excretion was increased (p‹0.05) 3 months after conversion. Withdrawal rate was 12.5%. Conclusions: Early conversion from CNI to SRL in low to moderate risk patients, is safe, well tolerated and associated with a significantly increase in estimated GFR following SRL introduction.

REFERENCES

1. Hariharan S, Johnson CP, Bresnahan BA et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.

2. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004; 4: 378–383.

3. Pascual M, Theruvath T, Kawai T et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med. 2002; 346: 580.

4. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003; 349: 2326,

5. Oberbauer R, Segoloni G, Campistol JM et al. Early cyclosporine withdrawal from a sirolimus based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int. 2005; 18: 22-28.

6. Watson CJ, Firth F, Williams PF et al. A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation. Am J Transpl. 2005: 5: 2496.

7. Mulay AW, Cockfi eld S, Stryker R, Ferguson D, Knoll GA. Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: A systematic review of the evidence. Transplantation. 2006; 82: 1153-1162.

8. Wali RK, Mohanlal V, Ramos E et al. Early withdrawal of calcineurin inhibitors and rescue immunosuppression with sirolimusbased therapy in renal transplant recipients with moderate to severe renal dysfunction. Am J Transpl 2007; 7: 1572-1583.

9. Schena FP, Pascoe MD, Alberu J et al. Conversion from calcineurin inhibitors to sirolimus: maintenance therapy in renal allograft recipients: 24 months: effi cacy and safety results from the CONVERT trial. Transplantation. 2009: 87: 233.

10. Martinez-Mier G, Avila-Pardo SF, Mendez-Lopez MT, Budar- Fernandez LF. Long-term results after conversion from calcineurin inhibitors to sirolimus in renal transplant patients. Clin Transpl. 2010 Jul; 24(4): 467-73.

11. Martínez-Mier G, Mendez-Lopez MT, Budar-Fernandez LF, Estrada- Oros J, Franco-Abaroa R, George-Micelli E, Rios-Martinez L, Mendez-Machado GF. Living related kidney transplantation without calcineurin inhibitors: initial experience in a Mexican center. Transplantation. 2006 Dec 15; 82(11): 1533-6.

12. Flechner SM, Goldfarb D, Solez K et al. Kidney transplantation with sirolimus and mycophenolate mofetil based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Transplantation. 2007; 83: 883.

13. Lebranchu Y, Snanoudj R, Toupance O, Weestel PF, Ligny BH, Buchler M, Rerolle JP, Thierry A, Moulin B, Subra JF, Deteix P, Pogamp PL, Finzi L, Etienne I. Five-Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The SPIESSER Study. Am J Transplant. 2012 Apr 5. doi: 10.1111/j.1600-6143.2012.04036

14. Ekberg H, Tedesco-Silva H, Demirbas A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.

15. Ekberg H, Bernasconi C, Tedesco-Silva H, Vítko S, Hugo C, Demirbas A, Acevedo RR, Grinyó J, Frei U, Vanrenterghem Y, Daloze P, Halloran P. Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. Am J Transplant. 2009 Aug; 9(8): 1876-85. Epub 2009 Jun 26.

16. Guba M, Pratschke J, Hugo C, et al. Renal Function, Effi cacy, and Safety of Sirolimus and Mycophenolate Mofetil After Short- Term Calcineurin Inhibitor–Based Quadruple Therapy in De Novo Renal Transplant Patients: One-Year Analysis of a Randomized Multicenter Trial. Transplantation. 2010; 90: 175–183.

17. Lebranchu Y, Thierry A, Toupance O, et al. Effi cacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: Concept study. Am J Transplant. 2009; 9: 1115–1123.

18. Lebranchu Y, Thierry A, Thervet E, Büchler M, Etienne I, Westeel PF, Hurault de Ligny B, Moulin B, Rérolle JP, Frouget T, Girardot-Seguin S, Toupance O. Effi cacy and safety of early cyclosporine conversion to sirolimus with continued MMF-fouryear results of the Postconcept study. Am J Transplant 2009; 9: 1115–1123.

19. Weir MR, Mulgaonkar S, Chan L, Shidban H, Waid TH, Preston D, Kalil RN, Pearson TC. Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial. Kidney Int. 2011. 79(8): 897-907.

20. Mosteller RD. Simplifi ed calculation of body-surface area. N Engl J Med. 1987; 317(17): 1098.

21. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular fi ltration rate from serum creatinine: a new prediction equation. Modifi cation of diet in renal disease study group. Ann Intern Med. 1999; 130: 461-470.